Nasdaq-listed IT company Cognizant has acquired digital marketing company Cadient Group, that serves a broad spectrum of life sciences companies, for an estimated $ 30 million.

“In an increasingly competitive industry with many digitally active stakeholders, the acquisition of Cadient Group will complement Cognizant’s digital and interactive solutions capability,” Cognizant’s Vice President and Global Markets Leader, Life Sciences Practice Shankar Narayanan said in a statement.

Cadient clients are spread across pharmaceutical, biotechnology, consumer health and medical device industries.

Cognizant has large presence in India. Its Healthcare and Life Sciences Practice group will manage the acquired company.

When contacted about the deal size, a Cognizant spokesperson said, “Cadient’s revenue is around $ 20 million and we paid approximately 1.5 times of the revenue.”

Cognizant serves 28 of the top 30 global pharmaceutical companies, 16 of the top 20 health plans in the US, four of the top five pharmacy benefit management companies in the US, nine of the top 10 biotech companies, and 12 of the top 15 medical device companies.

The company’s has reported $ 8.843 billion full year revenue for 2013. Annual revenue of its Healthcare and Life Sciences Practice group is about $ 2.5 billion.

Congnizant see this acquisition will further strengthens and expands its digital marketing capabilities. The terms of the transaction were not disclosed.

Pennsylvania-based Cadient Group has more than a decade of experience in providing digital strategy, marketing, and technology and analytics solutions to industry leaders and emerging companies in the life sciences industry.

As part of this acquisition, more than 100 digital specialists-with expertise across brand strategy and planning, content development, user-centered design, multi-channel analytics, and digital, social and mobile marketing-will join Cognizant.

ALSO READ  Turkey, Russia failed to reach common position on Syria’s Idlib – Source

This acquisition also brings to Cognizant digital assets and intellectual property of Cadient.

“Becoming a part of Cognizant uniquely positions us to deliver integrated solutions to life sciences marketing and sales teams around the world,” Cadient Group President and CEO Stephen Wray said.

Share this article:
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Notice: All comments represent the view of the commenter and not necessarily the views of AMN.

All comments that are not spam or wholly inappropriate are approved, we do not sort out opinions or points of view that are different from ours.

This is a Civilized Place for Public Discussion

Please treat this discussion with the same respect you would a public park. We, too, are a shared community resource — a place to share skills, knowledge and interests through ongoing conversation.

These are not hard and fast rules, merely guidelines to aid the human judgment of our community and keep this a clean and well-lighted place for civilized public discourse.

Improve the Discussion

Help us make this a great place for discussion by always working to improve the discussion in some way, however small. If you are not sure your post adds to the conversation, think over what you want to say and try again later.

The topics discussed here matter to us, and we want you to act as if they matter to you, too. Be respectful of the topics and the people discussing them, even if you disagree with some of what is being said.

Be Agreeable, Even When You Disagree

You may wish to respond to something by disagreeing with it. That’s fine. But remember to criticize ideas, not people. Please avoid:

  • Name-calling
  • Ad hominem attacks
  • Responding to a post’s tone instead of its actual content
  • Knee-jerk contradiction

Instead, provide reasoned counter-arguments that improve the conversation.

1 Comment
Most Voted
Newest Oldest
Inline Feedbacks
View all comments